Ruffer LLP’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-57,930
| Closed | -$3.94M | – | 90 |
|
|
2022
Q4 | $3.94M | Sell |
57,930
-221,057
| -79% | -$15M | 0.26% | 47 |
|
|
2022
Q3 | $15.3M | Sell |
278,987
-30,711
| -10% | -$1.69M | 0.96% | 32 |
|
|
2022
Q2 | $20.5M | Sell |
309,698
-1,294,931
| -81% | -$85.6M | 0.81% | 32 |
|
|
2022
Q1 | $106M | Sell |
1,604,629
-255,603
| -14% | -$17M | 2.49% | 12 |
|
|
2021
Q4 | $109M | Sell |
1,860,232
-111,564
| -6% | -$6.52M | 2.62% | 11 |
|
|
2021
Q3 | $117M | Buy |
+1,971,796
| New | +$117M | 3.7% | 9 |
|